BARCLAYS PLC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$065
-60.4%
0.00%
Q3 2019$0
-100.0%
164
-99.8%
0.00%
Q2 2019$146,000
+274.4%
86,144
+639.6%
0.00%
Q1 2019$39,00011,647
+18098.4%
0.00%
Q4 2018$0
-100.0%
64
-99.8%
0.00%
Q3 2018$216,000
-0.5%
35,149
+19.5%
0.00%
Q2 2018$217,000
+152.3%
29,407
+122.8%
0.00%
Q1 2018$86,000
-50.6%
13,201
-36.4%
0.00%
Q4 2017$174,000
-69.4%
20,746
-57.9%
0.00%
-100.0%
Q3 2017$569,000
+474.7%
49,282
+483.7%
0.00%
Q2 2017$99,000
-49.5%
8,443
-46.8%
0.00%
Q1 2017$196,000
+15.3%
15,876
+27.3%
0.00%
Q4 2016$170,000
+4150.0%
12,470
+5517.1%
0.00%
Q3 2016$4,000
-94.9%
222
-96.3%
0.00%
Q2 2016$78,000
+3800.0%
6,009
+3219.9%
0.00%
Q1 2016$2,000
-77.8%
181
-62.4%
0.00%
Q4 2015$9,000
+800.0%
482
+1020.9%
0.00%
Q3 2015$1,000
-66.7%
43
-72.8%
0.00%
Q2 2015$3,0000.0%158
+42.3%
0.00%
Q1 2015$3,0001110.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,051,441$3,070,0000.79%
X-Square Capital, LLC 109,832$321,0000.25%
KNOTT DAVID M 111,427$325,0000.15%
ARK Investment Management 1,033,491$3,018,0000.12%
Baker Brothers Advisors 2,677,818$7,819,0000.06%
HARVEY CAPITAL MANAGEMENT INC 31,200$91,0000.05%
DAFNA Capital Management LLC 30,000$88,0000.04%
WASATCH ADVISORS LP 953,368$2,784,0000.04%
FRANKLIN STREET ADVISORS INC /NC 51,415$150,0000.02%
FARALLON CAPITAL MANAGEMENT LLC 1,000,000$2,920,0000.02%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders